Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qingqing He has a total of 166 co-authors. Here are the top co-authors by number of shared publications:

  • Luming Zheng

    Department of General Surgery, The 960th Hospital of the PLA Joint Logistics Support Force, Jinan, Shandong, 250000, China

    18 shared publications
  • Peng Zhou

    Department of Thyroid and Breast Surgery, The 960th Hospital of People's Liberation Army, Jinan, China

    18 shared publications
  • Dayong Zhuang

    Department of Thyroid and Breast Surgery, The 960th Hospital of People's Liberation Army, Jinan, China

    14 shared publications
  • Jian Zhu

    Department of Thyroid and Breast Surgery, The 960th Hospital of the PLA Joint Logistics Support Force (Former Jinan Military General Hospital of People’s Liberation Army), Jinan, China

    14 shared publications
  • Tao Yue

    Department of Thyroid and Breast Surgery, The 960th Hospital of People's Liberation Army, Jinan, China

    11 shared publications
  • Ziyi Fan

    Department of Thyroid and Breast Surgery, The 960th Hospital of the PLA Joint Logistics Support Force (Former Jinan Military General Hospital of People’s Liberation Army), Jinan, China

    11 shared publications

Latest Publications

  • Open Access

    Exosomal miR‑145‑5p inhibits papillary thyroid cancer by targeting TPM3 and inactivating the PI3K‑Akt pathway

    by Yunfeng Weng, Xianjiao Cao, Wenyan Song, Qingqing He

    Within the present study, the objective was to investigate the effects of exosomal miR‑145‑5p on the proliferation, migration and invasion of papillary thyroid cancer (PTC) cells, and explore the molecular mechanism involved. Bioinformatics analyses based on numerous public databases were conducted to profile the expression of microRNA (miR)‑145‑5p and tropomyosin 3 (TPM3) in PTC and explore the associations between TPM3 expression, tumor stemness and immune infiltration. Exosomes were isolated and separately loaded with miR‑145‑5p mimics, miR‑145‑5p inhibitors or small interfering‑TPM3. Cellular uptake assay verified that PTC cells could efficiently internalize these modified exosomes. After uptake of the exosomes, colony formation, EdU and Transwell assays were applied to assess cell proliferation, migration and invasion. Western blotting and reverse transcription‑quantitative PCR were further performed to detect the expression levels of key proteins and genes involved in the PI3K‑Akt signaling pathway. Results showed miR‑145‑5p expression was elevated in the plasma exosomes of patients with PTC but decreased in PTC tissues. TPM3 was notably upregulated in thyroid cancer and its expression was associated with lymph node metastasis, tumor stemness and immune cell infiltration. Both miR‑145‑5p overexpression and TPM3 knockdown inhibited the malignant phenotypes of PTC cells and downregulated the activity of the PI3K‑Akt pathway. By contrast, miR‑145‑5p inhibitors reversed the above inhibitory effects. Overall, exosomal miR‑145‑5p suppresses PTC progression by targeting TPM3 and inhibiting the PI3K‑Akt signaling pathway. The present finding provides a novel molecular target and theoretical foundation for targeted therapy of thyroid cancer.

  • Evaluation of mitoxantrone hydrochloride injection versus carbon nanoparticle suspension in robotic thyroidectomy for papillary thyroid carcinoma

    by Bingxun Pan, Wentian Li, Zhonghui Li, Jingxiu Li, Tianyi Song, Tingting Han, Qingqing He, Peng Zhou

    This study aimed to evaluate whether mitoxantrone hydrochloride injection (MHI) provides lymph node tracing and parathyroid preservation outcomes comparable to those of carbon nanoparticle suspension injection (CNP) during robotic thyroidectomy for papillary thyroid carcinoma (PTC). We conducted a retrospective review of 507 patients with PTC who underwent robotic thyroidectomy from September 2024 to September 2025. Patients were categorized into CNP and MHI groups based on the tracer utilized. After 1:1 propensity score matching, 62 matched pairs were selected for the final analysis. The primary outcomes encompassed the counts of dissected, metastatic, and stained lymph nodes, along with outcomes related to parathyroid preservation. Secondary outcomes included perioperative parameters and postoperative complications. After matching, the baseline characteristics of the two groups were well balanced. There were no notable differences in the counts of total lymph nodes, metastatic lymph nodes, stained level VI lymph nodes, parathyroid autotransplantation, incidental parathyroid resection, or intraoperative parathyroid identification. Preoperative, postoperative day 1, and 6-month postoperative serum calcium and parathyroid hormone (PTH) levels were comparable between the groups. Surgical recovery indicators and postoperative complication rates were also similar between the groups. In this single-center, propensity score-matched retrospective study, MHI showed efficacy and safety similar to those of CNP in lymph node tracing and parathyroid preservation. These findings suggest that MHI may be a practical alternative tracer in robotic thyroid cancer surgery.

  • Bidirectional risk stratification of calcium disturbances after parathyroidectomy in dialysis patients with secondary hyperparathyroidism: development and validation of a multinomial nomogram

    by Wentian Li, Wei Wei, Tianyi Song, Zhonghui Li, Ying Wang, Qingqing He, Peng Zhou

    We constructed a multinomial nomogram to predict postoperative hypocalcemia and hypercalcemia following parathyroidectomy (PTX) in dialysis patients with secondary hyperparathyroidism (SHPT). We analyzed 685 dialysis patients undergoing PTX between January 2013 and May 2025. Patients were randomly allocated into a training cohort (n = 479) and a validation cohort (n = 206) in a 7:3 ratio. Independent predictors of postoperative calcium levels were identified using a multinomial logistic regression model. Model performance was internally validated using 200 bootstrap resamples and assessed by the area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis (DCA). Postoperative hypocalcemia occurred in 21.2% (n = 144) of patients, while 10.5% (n = 72) developed hypercalcemia. The final nomogram incorporated seven clinical variables: gender, dialysis duration, preoperative serum calcium, parathyroid hormone (PTH), alkaline phosphatase (ALP), C-terminal telopeptide (CTX), and intraoperative PTH (ioPTH). The nomogram demonstrated excellent discrimination, achieving a macro-AUC of 0.87 (95% CI: 0.84, 0.90) in the training set and 0.81 (95% CI: 0.76, 0.86) in the validation set. Calibration curves exhibited concordance between predicted probabilities and actual outcomes, and DCA confirmed that the model provides a clinical net benefit across probability thresholds of 0 to 0.45 for both abnormal calcium states. This nomogram accurately stratifies the risk of bidirectional calcium disturbances in SHPT patients, empowering clinicians to optimize perioperative monitoring and individualized supplementation strategies.

  • Open Access

    A Pilot Study of Telerobotic Radical Thyroidectomy for Thyroid Cancer Using a 5G Network

    by Bing Wang, Chen Li, Zheng Wan, Jian Zhu, Meng Wang, Yanbing Jian, Zelong Yang, Xin Miao, Linlin Zhang, Fei Kuang, et al.

    Background: The incidence of thyroid cancer has increased globally. In recent years, robotic surgical systems have been applied in thyroid surgery, and the rapid development of fifth-generation (5G) communication technology has laid a solid foundation for the smooth implementation of remote surgery. Objective: The aim was to explore the feasibility and safety of telerobotic radical thyroidectomy using 5G communication technology to treat thyroid cancer. Methods: From August 2024 to October 2024, telerobotic radical thyroidectomy was performed on seven female patients using a 5G wireless network and a dedicated line network (or ordinary wired broadband) spanning 22–2200 km. The patients’ clinical and information transmission data were analyzed. Results: All patients (papillary thyroid carcinoma, female, with an average age of 44.0 ± 4.6 years) underwent uneventful surgical procedures without any transfer to open surgery or complications. The average surgical duration was 91.3 ± 11.8 min, the average blood loss was 11.4 ± 4.8 mL, and the average postoperative hospital stay was 3.6 ± 0.8 days. All subjects were successfully discharged within 5 days after surgery. The average total latency time of the intraoperative network was 137.5 (range, 121–159) ms, and there were no adverse events, such as network disconnection, frame loss, or network attacks. The operator worked smoothly without any obvious delay or lag, and the recorded audio and video are clear. Conclusions: Telerobotic radical thyroidectomy for thyroid cancer over a 5G network demonstrates promising feasibility and safety. With stable network transmission and a clear surgical field, the precise operations required in thyroid surgery can be performed reliably. These findings suggest that this technology can facilitate high-quality surgical care in remote areas, contributing to a more balanced distribution of medical resources.

  • Open Access

    Utilities of next-generation sequencing in the surgical management of thyroid nodules in China

    by Kaige Lin, Xuan Xin, Jinge Liu, Fuyun Shi, Luming Zheng, Qingqing He, Yunhan Ma

    This study aimed to evaluate the diagnostic utility of next-generation sequencing (NGS) for identifying genetic alterations in fine-needle aspiration (FNA) samples from thyroid nodules, with a specific focus on its clinical implications for surgical management. In total, 631 patients underwent FNA cytology, yielding 683 cytological samples. Of these, 264 patients with indeterminate or suspicious cytological results underwent surgical intervention, and their samples were subjected to molecular analysis targeting single-nucleotide variants (SNVs) and insertion/deletion (InDel) mutations in a 20-gene panel associated with thyroid carcinoma. Genetic alterations were identified in 160 (57.55%) nodules, while 118 (42.45%) exhibited no detectable mutations. Co-occurrence of multiple genetic mutations was noted in 39 nodules (14.03%). When noninvasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP) and tumors with uncertain malignant potential were considered malignant, the NGS test demonstrated a sensitivity of 66.67% (95% CI: 49.69%–80.41%) and specificity of 72.34% (95% CI: 57.13%–83.91%) specifically for nodules with indeterminate cytology (Bethesda categories III and IV). The BRAF V600E mutation was the most frequently observed genetic alteration in papillary thyroid carcinoma (PTC). The classic subtype of papillary thyroid carcinoma (PTC) was the most prevalent, followed by the infiltrative follicular variant and the tall cell subtype. The tall cell subtype showed strong associations with key molecular alterations, including BRAF V600E, TERT promoter, and TP53 mutations. These findings highlight the potential of NGS-based molecular profiling to enhance diagnostic accuracy, inform risk stratification, and guide personalized surgical approaches in thyroid nodule management.

  • Open Access

    Mechanisms and clinical prospects of mesenchymal stem cells and their derivatives in treating hypothyroidism-induced injuries: A focus on cardiovascular, skeletal muscle, and nervous systems

    by Yue Wang, Jiayu Zhu, Zhonghui Li, Fang Yu, Yuanyuan Fu, Han Gao, Meng Wang, Yuan Liu, Luming Zheng, Qingqing He

    Hypothyroidism, a prevalent endocrine disorder characterized by insidious onset and prolonged progression, leads to metabolic slowdown and multiorgan dysfunction, significantly compromising patients’ quality of life. While hormone replacement therapy improves most patients’ serum thyroid function, it faces limitations, including individual response variations, lifelong medication requirements, and potential risks, with no reversal of existing tissue damage. In recent years, the mesenchymal stem cells (MSCs) and their derivatives have gained prominence in immunomodulation and regenerative medicine because of their abundant sources, low immunogenicity, potent paracrine effects, and multidirectional differentiation capabilities for tissue repair. Their unique advantages in modulating the immune microenvironment, promoting angiogenesis, reducing fibrosis, and stimulating endogenous cell regeneration offer novel strategies to overcome treatment bottlenecks in hypothyroidism and its complications, effectively repairing thyroid and multiorgan damage in animal models. This review synthesizes literature from the PubMed and Web of Science databases, incorporating relevant basic research and clinical trials. This study examined the systemic impacts of hypothyroidism, evaluated the experimental and clinical roles of the MSCs in thyroid tissue reconstruction and organ protection, and analyzed molecular mechanisms, including immune regulation, the antioxidant stress response, anti-apoptosis, and cellular function restoration. Clinical application potential is assessed alongside critical challenges such as standardized preparation, long-term safety, in vivo homing efficiency, and large-scale production.

  • Open Access

    Development and Validation of a Nomogram for Post-Parathyroidectomy Hypocalcemia in Secondary Hyperparathyroidism

    by Wentian Li, Ying Wang, Jing Xu, Zhonghui Li, Peng Zhou, Qingqing He

    Aims/Background: Severe hypocalcemia (SH) is a common and serious complication after parathyroidectomy (PTX) in patients with secondary hyperparathyroidism (SHPT). However, accurately predicting high-risk patients remains challenging. This study aimed to develop and validate a linear predictive model to identify these patients preoperatively. Methods: From January 2013 to May 2025, 755 total parathyroidectomy (TPTX) or TPTX with autotransplantation (TPTX-AT) were performed by a single surgical team at the 960th Hospital of the PLA Joint Logistics Support Force. After applying inclusion and exclusion criteria, 685 patients were enrolled and randomly divided (7:3) into training and validation cohorts. Variables associated with serum calcium levels on the first postoperative day (POD1 Ca) were identified through linear regression analysis in the training cohort. Model validity was assessed using ten-fold and leave-one-out cross-validation. Bland-Altman plots and paired t-tests evaluated agreement within groups. Model performance in the validation cohort was measured using bias, precision, and accuracy metrics. Results: Significant predictors of POD1 Ca included TPTX-AT (β [95% confidence interval (CI)]: –0.055 [–0.119, –0.001]), parathyroid hormone (PTH) (–0.078 [–0.115, –0.041], ng/mL), C-terminal cross-linked telopeptide of type I collagen (CTX) (–0.147 [–0.198, –0.096], μg/L), preoperative serum calcium (0.626 [0.516, 0.736], mmol/L), and alkaline phosphatase (ALP) (–0.018 [–0.024, –0.012], μkat/L). Bland-Altman analysis showed good agreement in the validation cohort (bias <0.001, 95% limits of agreement [LoA]: –0.507, 0.566). Conclusion: The nomogram provides an accurate, individualized prediction of postoperative hypocalcemia risk after parathyroidectomy, supporting tailored clinical management of SHPT patients.

  • Open Access

    Establishment and investigation of a surgical model of hypothyroidism in Wistar rats

    by Yue Wang, Jiayu Zhu, Fang Yu, Han Gao, Yuanyuan Fu, Chunyu Chu, Chao Yu, Zhonghui Li, Xiao Liu, Meng Wang, et al.

    Background: The purpose of this study was to investigate the surgical model of hypothyroidism in rats and the feasibility and stability of the model. Methods: Forty-eight adult male Wistar rats were randomly divided into 12 sham-operated rats (control group) and 36 operated rats (18 rats in the group with total thyroidectomy and 18 rats in the group with subtotal thyroidectomy). Thyroid-stimulating hormone (TSH), free thyroxine (FT4), and free triiodothyronine (FT3) serum concentrations were measured prior to surgery and on postoperative days 14, 28 and 90; blood calcium (Ca), blood phosphorus (P), and parathyroid hormone (PTH) concentrations were measured on postoperative day 10; and thyroglobulin (Tg) concentrations were measured on postoperative day 60. The postoperative behavioral status of the rats was comprehensively evaluated on the basis of behavioral indicators. Results: There was no significant difference in preoperative TSH, FT4, or FT3 between the control and surgical groups ( p > 0.05). On postoperative day 10, there were no significant differences in Ca, P, or PTH levels among the groups ( p > 0.05). On postoperative days 14, 28 and 90, the TSH level was greater, whereas the FT4 and FT3 levels were lower in the surgical group ( p < 0.05). On the 60th postoperative day, the Tg was significantly lower in the surgical group ( p < 0.05). Conclusion: Surgical removal of the thyroid gland can be used to successfully establish a hypothyroid rat model that is stable and reliable and can provide a model basis for hypothyroidism-related research.

  • Open Access

    Prediction of malignancy risk in Bethesda III nodules: development and validation of multiple machine learning models

    by Wentian Li, Jiayu Zhu, Ying Wang, Jingxiu Li, Zhonghui Li, Cuicui Wang, Jingli Xue, Peng Zhou, Qingqing He

    Objective: To develop and validate a machine learning (ML)-based prediction model of Bethesda III nodules and create a nomogram based on the best model.Methods: We collected data on patients with Bethesda III nodules who were admitted between January 2020 and June 2024, including 276 Bethesda III nodules from 7371 patients who underwent ultrasound-guided fine needle aspiration (US-FNA). Clinical, ultrasonographic, cytological, laboratory, and molecular data were collected and randomly split into training and validation cohorts at a ratio of 7: 3. Six feature selection methods and ML algorithms—Logistic Regression (LR), Decision Tree (DT), Random Forest (RF), Extreme Gradient Boosting (XGB), Support Vector Machine (SVM), and K-Nearest Neighbors (KNN)—were evaluated. A nomogram was then created based on the best-performing model.Results: The study cohort included 276 Bethesda III nodules with a final malignancy rate of 65.2% (180/276). LR exhibited the highest area under the receiver operating characteristic (ROC) curve (AUC: 0.823) in cross-validation of the validation set. Additionally, the calibration curves and Decision Curve Analysis (DCA) results were also favorable. The model included BRAF, composition, shape, orientation, and the thyroid imaging reporting and data system (TI-RADS). The nomogram exhibited robust discrimination (AUC: 0.846 in the validation set), calibration, and clinical applicability across the two datasets after 500 bootstraps.Conclusion: Among the six ML algorithms, the LR algorithm demonstrated the best performance. A nomogram was developed to predict the malignancy risk in Bethesda III nodules. This nomogram may serve as a valuable tool to reduce diagnostic uncertainty and provide personalized risk stratification for patients.


  • Retrospective propensity score-matched comparison of robotic versus open bilateral lateral neck dissection in papillary thyroid carcinoma with bilateral lateral neck metastasis

    by Xiaolei Li, Sijuan Chen, Yan Liu, Xianjiao Cao, Gaoyuan Xu, Lanqing Chen, Qingqing He

    Our study aimed to evaluate and compare the surgical and oncological outcomes of robotic bilateral lateral neck dissection (LND) via the bilateral axillo-breast approach (BABA) with the conventional open procedures (COP) in patients with papillary thyroid carcinoma (PTC) and bilateral lateral neck metastasis (LNM). The clinical data of 181 patients with PTC and bilateral LNM who underwent robotic bilateral LND or COP (61:120) between April 2018 and February 2024 at our institution were retrospectively analyzed. 36 matched pairs were generated using a 1:1 propensity score matching (PSM) method. All robotic BABA bilateral LND procedures were successfully completed without conversion to open surgery. PSM analysis revealed that the postoperative stay, drainage volume, and the numbers of retrieved or metastatic lymph nodes were comparable between the matched groups. However, the operating time was significantly longer in the robotic group compared to the open group (p < 0.001). Furthermore, there were no significant differences between the two groups in terms of hypoparathyroidism (p = 0.637), vocal cord palsy (p = 1), and chyle leakage (p = 1). Additionally, there was no recurrence in either group. Notably, the aesthetic score was significantly higher in the robotic group compared to the open group (median, [IQR] 9 [IQR: 8-10] versus. 5 [IQR: 3-5], p < 0.001). Robotic BABA bilateral LND resulted in comparable surgical outcomes and superior cosmetic in a cohort of patients with papillary thyroid carcinoma and bilateral lateral neck metastasis.